Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Rat Tumor Marker Inhibitors

Rat Tumor Marker Inhibitors are a class of chemical compounds specifically designed to target and inhibit proteins or other biomolecules that are identified as tumor markers in rat models. Tumor markers are substances, often proteins, that are produced by tumor cells or by the body in response to the presence of a tumor. These markers can be involved in various cellular processes, including cell growth, division, and signaling, and are typically overexpressed or uniquely expressed in tumor cells compared to normal tissues. Inhibitors targeting these tumor markers are developed to modulate their activity, allowing researchers to study the role of these markers in tumor development, progression, and cellular behavior in rat models.

The development of Rat Tumor Marker Inhibitors begins with the identification and characterization of specific tumor markers that are prominently expressed in rat tumor models. Once a target marker is identified, its molecular structure is analyzed using techniques such as X-ray crystallography, cryo-electron microscopy, or nuclear magnetic resonance (NMR) spectroscopy to determine its three-dimensional configuration. This structural information is crucial for understanding how the tumor marker interacts with other molecules and identifying potential sites where inhibitors can bind. Computational tools like molecular docking and virtual screening are then employed to discover small molecules that can bind to these sites with high affinity, effectively inhibiting the marker's function. After potential inhibitors are identified, they undergo synthesis and are tested in vitro to evaluate their binding properties, specificity, and inhibitory potency. Through iterative optimization, the chemical structure of these inhibitors is refined to enhance their effectiveness and stability. The study of Rat Tumor Marker Inhibitors provides insights into the biological functions of these markers and contributes to a deeper understanding of tumor biology in rat models, which can be valuable for studying tumor mechanisms and progression in a controlled experimental setting.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Modulates NF-κB pathway, potentially decreasing expression of tumor markers by affecting transcription.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Influences Sirtuin pathways, which may indirectly modulate the expression of proteins associated with tumor markers.

Metformin

657-24-9sc-507370
10 mg
$79.00
2
(0)

Activates AMPK pathway, possibly influencing metabolic states that could modulate tumor marker levels.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Inhibits mTOR pathway, potentially affecting cellular stress responses and tumor marker expression.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

Modulates multiple signaling pathways including those involved in inflammation, potentially affecting tumor marker expression.

D,L-Sulforaphane

4478-93-7sc-207495A
sc-207495B
sc-207495C
sc-207495
sc-207495E
sc-207495D
5 mg
10 mg
25 mg
1 g
10 g
250 mg
$153.00
$292.00
$489.00
$1325.00
$8465.00
$933.00
22
(1)

Activates Nrf2 pathway, potentially upregulating antioxidant responses that indirectly modulate tumor markers.

Tamoxifen

10540-29-1sc-208414
2.5 g
$272.00
18
(2)

Estrogen receptor modulator, could influence hormone-responsive tumor markers and their expression.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Tyrosine kinase inhibitor, might affect signaling pathways that regulate tumor marker proteins.

Vemurafenib

918504-65-1sc-364643
sc-364643A
10 mg
50 mg
$117.00
$423.00
11
(1)

BRAF inhibitor, potentially affecting pathways that regulate the expression of tumor markers in melanoma.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

RAF inhibitor, might alter signaling pathways affecting tumor marker expression in various cancers.